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Helicobacter pylori is a late-in-life human pathogen
with potential early-life benefits. Although H. pylori
is disappearing from the human population, little is
known about the influence of H. pylori on the host’s
microbiota and immunity. Studying the interactions
of H. pylori with murine hosts over 6 months, we
found stable colonization accompanied by gastric
histologic and antibody responses. Analysis of
gastric and pulmonary tissues revealed increased
expression of multiple immune response genes,
conserved across mice and over time in the stomach
andmore transiently in the lungs. Moreover, H. pylori
infection led to significantly different population
structures in both the gastric and intestinal micro-
biota. These studies indicate that H. pylori influences
the microbiota and host immune responses not only
locally in the stomach, but distantly as well, affecting
important target organs.INTRODUCTION
Starting at birth, humans are extensively exposed to a wide va-
riety of microbial cells, which colonize the inner and outer sur-
faces of our body and subsequently shape our immune system
and physiology (Dominguez-Bello et al., 2010; Hooper et al.,
2012). The gastro-intestinal tract is one of the most densely
populated sites in the human body and accordingly plays amajor
role in the development of the immune system (Goodnow et al.,
2005; Kabat et al., 2014). Later in life, disruption of this microbial
community may lead to disease consequences (Buffie et al.,
2015; Ho¨genauer et al., 2006); conversely, restoration of
impacted microbial community could be an efficient approach
for their reduction (Reid et al., 2011; van Nood et al., 2013).
Despite its acidic environment, the human stomach is home to
a diverse microbial community (Bik et al., 2006; Maldonado-Cell RContreras et al., 2011). Depending on the gastric milieu, the
composition and functions of the microbial community can
vary (Manson et al., 2008; Martinsen et al., 2005). A prominent
member of the gastric microbiota is Helicobacter pylori; in colo-
nized humans, its relative abundance usually is high but can vary
(Bik et al., 2006). H. pylori is typically acquired early in life
(Goodman et al., 1996; Kumagai et al., 1998), often transmitted
from mothers (Pe´rez-Pe´rez et al., 2003; Thomas et al., 1999),
and persistently colonizes the gastric mucosa (Oertli et al.,
2013). Unless antibiotic therapy is used, colonization generally
persists for decades or throughout the entire host lifespan (Ko-
sunen et al., 1997).H. pylori carriage is associated with illnesses,
such as peptic ulcer disease, gastric cancer, and mucosa-asso-
ciated lymphoid tissue (MALT) lymphoma (Ernst and Gold,
2000). For decades, H. pylori research has focused on under-
standing the pathogenesis of these diseases (Amieva et al.,
2003; Mahdavi et al., 2002; Odenbreit et al., 2000; Robinson
et al., 2008).
H. pylori prevalence in populations in developed countries is
diminishing due to changing hygienic standards and antibiotic
treatments. Despite the significance of H. pylori as a pathogen,
concerns have been raised about the consequences of the
loss of an organism that has colonized humans for >100,000
years (Moodley et al., 2012). Inverse associations of H. pylori
with diseases, including early-onset asthma (Arnold et al.,
2011a; Chen and Blaser, 2007, 2008), gastro-intestinal (Cohen
et al., 2012; Higgins et al., 2011; Rothenbacher et al., 2000)
and systemic (Perry et al., 2010) infections, and Barrett esoph-
agus and its consequences (Corley et al., 2008; Rubenstein
et al., 2014; Thrift et al., 2012) have been observed. In mice,
the age at which H. pylori is acquired is critical in influencing out-
comes; challenged adult mice developed pre-neoplastic lesions,
but neonatal mice were protected against severe pathology by
immune tolerance (Arnold et al., 2011b). The fact that this toler-
ance subsequently protected against the development of
asthma (Arnold et al., 2011a) highlights the importance of
cross-talk between particular bacterial colonizers and the host’s
immune system. During the first years of life, the development
and maturation of the mammalian immune system is stronglyeports 14, 1395–1407, February 16, 2016 ª2016 The Authors 1395
AB
C Figure 1. Bacterial Colonization and HostAntibody and Ghrelin Responses of C57Bl/6
Mice Infected with H. pylori Strain PMSS1
(A) Colony-forming units (Cfus) per gram stomach in
animals sacrificed at the indicated times post-infec-
tion. Bars indicate the medians; %+ indicates
percent of mice positive for H. pylori, as determined
by culture for each time point of sacrifice; and total
percentage and number of (positive/total number) of
mice are shown in bottom line.
(B) Antibody responses. Early (first 25 days following
challenge) and long-term (over 6 months) anti-
H. pylori IgM and IgG responses of control and in-
fected mice expressed in optical density ratios
(ODRs). (+) or (*) indicates when IgM or IgG levels,
respectively, were significantly higher compared to
baseline; Mann-Whitney U test; +,*p < 0.05;
(C) Ghrelin responses. Levels of total plasma ghrelin
measured over the 6-month challenge (horizontal
bars represent mean values). Bottom strip: D Ghrelin
represents changes of ghrelin over time for controls
(open triangles) and infected mice (black triangles);
Kruskal-Wallace followed by Mann-Whitney U test;
**p < 0.001.
See also Figure S1.dependent on the micro-organisms to which it is exposed, and
simultaneously, the immune system shapes the composition of
our residential bacterial community (Hooper and Macpherson,
2010); the two phenomena are cross-linked.
Studies to explore the potential effects of H. pylori using the
C57BL/6 mouse model and the functional CagA H. pylori strain
PMSS1 highlight the importance of the developmental stage of
the mouse at time of infection (Arnold et al., 2011a, 2011b; Oertli
and M€uller, 2012; Oertli et al., 2012, 2013). However, the most-
relevant time windows are not yet known, nor are the direct or
indirect influences of H. pylori on gastric and gut microbial com-
munities and immunity. The goal of the current study was to un-
derstand the effect of gastric H. pylori colonization on local and
systemic immune responses and whether it affects the compo-
sition of the gastro-intestinal microbiota.
RESULTS
C57Bl/6 Mice Were Stably Colonized with H. pylori
PMSS1
We first examined whether experimental challenge with
H. pylori strain PMSS1 would lead to productive infection re-
sulting in stable colonization in cohort 1 (infected at 4 weeks
of age) and cohort 2 (age 6 weeks) mice (Figure S1). Culture
and PCR analyses of the two cohorts detected H. pylori infec-
tion in 44 of 46 challenged mice but in none of 40 non-chal-
lenged control mice, as expected. During the first month
following challenge, the levels of colonization varied exten-
sively (range 102 to 108 colony-forming units [CFUs] per gram1396 Cell Reports 14, 1395–1407, February 16, 2016 ª2016 The Authorsstomach) but then stabilized (Figure 1A).
In most challenged mice, H. pylori were
detected by culture and confirmed by
PCR or by PCR alone (Figures 1A andS1). The only twomice that were both culture and PCR negative
had antibody responses to H. pylori and high gastric histologic
inflammatory scores, with characteristic organisms visualized.
Taken together, all 48 H. pylori-challenged mice were success-
fully infected and control mice were all culture and PCR nega-
tive (Figure S1). Over the 6-month study period, all mice,
regardless of age at challenge, were stably H. pylori infected
(median colonization 105–106 CFUs/g of stomach; Figure 1A),
corresponding to 105 CFUs per mouse stomach.
Challenged Mice Displayed High Levels of Antibodies
against H. pylori Whole-Cell Lysates, but Not to CagA
Examining IgM and IgG responses to H. pylori (Figure 1B), con-
trol mice showed no responses, but the challenged mice had
IgM responses detected as early as day 5. IgM levels declined
by 1 month post-infection but remained significantly elevated
compared to baseline and to controls. IgG levels rose signifi-
cantly 13 days post-infection compared to the controls and
remained elevated throughout the experiment (Figure 1B), with
cohorts 1 and 2 essentially identical; however, no antibodies
against CagA were detected at any time point in any mouse
(data not shown). Nevertheless, these studies provide evidence
of robust immunologic recognition ofH. pylori beginning soon af-
ter challenge, independent of mouse age.
Ghrelin Was Elevated in H. pylori-Infected Mice
Because gastric H. pylori colonization in humans affects circu-
lating metabolic hormones (Francois et al., 2011; Yap et al.,
2015), we examined fasting ghrelin, leptin, insulin, and peptide
Figure 2. Histopathology and Gastric Inflammation Scores of Control and H. pylori-Infected C57Bl/6 Mice
(A) Histology. (I and II) Control mice with no inflammation in the glandular stomach are shown. (III and IV) Low- to medium-grade inflammation with abundant
lymphocytes and sparse neutrophilic granulocytes in an infected mouse are shown; representative photomicrographs were obtained from a mouse sacrificed
6 months post-infection. (V and VI) Severe chronic active inflammation with abundant lymphocytes and neutrophilic granulocytes in an infected mouse is shown
(3 months post-infection). Upper row (I, III, and V): 403 magnification; lower row (II, IV, and VI): 2003 magnification. The scale bars represent 100 mm.
(B) Inflammation scores for antrum and corpus. C, control; I, infected. Active and chronic inflammation scores are combined.
(C) Total inflammation scores of control andH. pylori-infectedmice by month. Active and chronic inflammation of corpus and antrum are combined. n, number of
mice per group in which total inflammation score was determined. Bars indicate the medians.
Mann-Whitney U test; **p < 0.02; ***p < 0.0001. See also Figure S2.YY in plasma at sacrifice (Figure 1C). Ghrelin levels in control
mice dropped significantly with age. In contrast, ghrelin levels
of infected mice progressively rose until month 3 post-infection
and diminished thereafter, with the same trend in both cohorts.
No significant differences between the control and infected
mice were detected for the other hormones tested (data not
shown), indicating specific effects for ghrelin, the major meta-
bolic hormone produced in the stomach.
Gastric Histopathology
To determine whether this experimental infection elicited specific
tissue responses, we evaluated gastric pathology in all animals at
sacrifice. In general, the control mice displayed no inflammation
versus notable inflammatory changes in the infected mice,Cell Rwithout significant differences between both cohorts (Figures
2A and S2). Compared to controls (Figures 2A, panels I and II,
and S2A), tissues from infectedmice showed gastric corpus infil-
trationwith inflammatory cells and to a lesser extent in the antrum
(Figures 2A, panels III–VI, S2B, and S2C). The inflammatory infil-
trate, consisting of lymphocytes, plasma cells, and neutrophils in
the lamina propria, was arranged around the gastric glands, ex-
tending in severe cases to the submucosa (Figures 2A, panels
III–VI, and S2C) with abundant neutrophils in the gastric pits (Fig-
ure 2A, panel VI), with inflammation sometimes pronounced adja-
cent to the esophageal-gastric junction (Figure S2D). In other
cases, lymphoid follicles were visible (Figure S2E) in the gastric
antrum (Figure S2F). Higher magnification showed a mixed in-
flammatory infiltrate involving gastric glands, mirroring humaneports 14, 1395–1407, February 16, 2016 ª2016 The Authors 1397
Table 1. Number of Immune Genes with Significant Changes in Expression
Stomach Lung
1 Month 3 Months 6 Months 1 Month 3 Months 6 Months
Total 109 158 317 29 10 0
Up 88 134 282 24 5 0
Down 21 24 35 5 5 0
Shared (months) 1 and 3 3 and 6 1, 3, and 6 1 and 3 3 and 6 1, 3, and 6
Total 64 142 64 3 0 0
Up 57 130 57 1 0 0
Down 7 12 7 2 0 0
Number of the 547 genes in the Nanostring (nCounter) Mouse Immunology Panel that were significantly differentially expressed, based on H. pylori
colonization status; FDR-adjusted p value < 0.5; t test. Up and down refers to increased or decreased expression in tissue from mice colonized
with H. pylori compared to controls, respectively. Shared represents genes with significant differential expression in the same direction at months
1 and 3, 3 and 6, or months 1, 3, and 6. See also Figure S4.type B gastritis (Figures S2G and S2H). Rod-shaped bacteria,
typical forH. pylori,were visible in several colonized animals (Fig-
ure S2I). Histopathological validation, according to the Sidney
classification (Mainguet et al., 1993), showed that, as expected,
scores were low in controls (Figures 2B and 2C), and infected
mice had higher scores in both corpus and antrum (Figure 2B),
trending toward more severe tissue injury at 3 and 6 months
(Figure 2C).
H. pylori Modulates Immune Gene Expression in a
Tissue-Specific Manner
To assess the extent to which H. pylori influences immune gene
expression of local and distant tissues, we examined gastric and
pulmonary genes related to host immune and inflammatory re-
sponses in mice infected at 4 weeks (cohort 1) with respect to
uninfected mice. Unsupervised hierarchical cluster analysis re-
vealed that themajor separation of samples was based on tissue
location, as expected (Figure S3), and that the secondary branch
points generally separated samples based on H. pylori status,
with stronger effects in the stomach than in the lung. H. pylori
gastric infection led to more upregulation of immune response
genes than downregulation (Table 1). The differences in gene
expression in the stomach between infected and control mice
progressively increased over the course of the infection, and
several genes were consistently altered (Figures 3A and 3B;
Data S1).
Genes altered in both the stomach and lung included those
upregulated in both tissues and those regulated in opposing di-
rections (Figures 3D–3F and S3B). Using ingenuity pathways
analysis, upregulated pathways, including those for T cell activa-
tion (NFAT, iCOS, and TREM1) and pro-inflammatory molecules
(nitric oxide [iNOS]), were more frequent than downregulated
canonical pathways in the gastric samples from the H. pylori-in-
fected mice, with alteration intensity generally increasing over
time (Figure 3C). By 6 months post-challenge, 317 (58%) of the
547 investigated genes were significantly upregulated (Table 1),
with >10%shared at all time points studied. Apoptosis pathways
were significantly upregulated only at later time points. In the pul-
monary samples, biological functions in response to H. pylori
infection involved leukocyte development and migration, as
well as T cell differentiation (Figure S3D). Altogether, the lung1398 Cell Reports 14, 1395–1407, February 16, 2016 ª2016 The Authand stomach have distinct H. pylori-modulated immune expres-
sion profiles.
Pulmonary T Cell Infiltration in H. pylori-Infected Mice
To further assess systemic immunologic effects of the H. pylori
infection, we examined splenic and pulmonary tissues by flow
cytometric analysis of CD4+ cells and their RoRgT-, IL17a-pos-
itive (Th17), and FoxP3-positive (T-regulatory [T-reg]) subsets
(Figures 4 and S4). Splenic cells from infected mice trended
toward increased Th17 populations, but differences were not
significant. However, in the pulmonary tissues, the H. pylori-in-
fected mice showed higher levels of CD4+ RORgT-positive cells
(Figure 4B) and CD4+ IL17-positive cells at least at month 1 after
infection (Figure S4) compared to controls. CD4+ FoxP3-positive
(T-reg) cells did not significantly differ (Figure 4C). These effects
were more prominent in the cohort infected at a younger age
(Figure S4). Although effects were modest and not completely
consistent over time, differential presence of CD4+ RORgT-pos-
itive cells compared to controls might provide indication of non-
local immunologic effects of gastric H. pylori infection, targeting
the lungs.
H. pylori Influences the Gastric Microbial Community
Structure
Assessing microbial diversity in the gastric samples, using the
number of observed species and the Shannon index (Figure S5),
there were no substantial changes over the experimental course
or in relation to H. pylori status. Next, using UniFrac analysis, we
addressed whether the community structure (b-diversity) of the
two experimental cohorts varied (Figures 5 and S5); reflecting
founding microbial population differences common to commer-
cially obtained mice, the two control groups differed significantly
(Figure 5A), and the control and treatment groups within each
cohort weremore similar to each other than to the corresponding
group in the other cohort. Examining the cohorts individually,
control and treatment groups separated as early as 1 month
post-challenge (Figure 5B). For both cohorts, control and treat-
ment samples moved monotonically over time and remained
significantly (p < 0.05; ADONIS test) separated to the experi-
ment’s end (Figures 5B and S5). Thus, H. pylori infection clearly
affected the gastric microbial population structure.ors
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Figure 3. Immunologic Genes Consistently Altered by Gastric H. pylori Infection in Stomach and Lung
(A and B) Immunologic gene expression was measured by hybridization using Nanostring (nCounter) technology in (A) gastric and (B) pulmonary tissues at 1, 3,
and 6months after colonization in cohort 1mice. Heatmaps show expression levels of genes significantly different (FDR-adjusted p value < 0.05; t test) at all three
time points for the stomach and at two time points for the lung.
(C) Gastric canonical pathways, significantly induced or repressed by H. pylori infection.
(D–F) Relative expression levels (normalized counts) for genes significantly different in greater than or equal to two time points in each tissue. False-discovery-
rate-adjusted p values: *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S3.Relative Microbial Abundances in the Mouse Stomach
Are Influenced by the Presence of H. pylori
Although cohorts 1 and 2 were compositionally distinct, H. pylori
presence had greater impact in the younger cohort (Figure S6A).Cell RIn agreement with culture and PCR results, H. pylori-specific se-
quences were not detected in any of the control mice but were
present in most of the infected mice over a range of three
log10; relative abundance varied between 0.01% and 10%eports 14, 1395–1407, February 16, 2016 ª2016 The Authors 1399
Figure 4. Increased Proportions of CD3+
CD4+ RORgT+ Cells in the Lungs of
H. pylori-Infected Mice
(A) Gating strategy. Flow cytometry was per-
formed on pulmonary specimens from control and
H. pylori-infected mice. CD3, CD4, and CD8 sur-
face stains and a viability stain were used to
identify live T-helper cells. Nuclear staining for
RORgT and FoxP3 was performed to identify Th17
and T-reg cells. A representative example of
RORgT+ and FoxP3+ expression of CD4+ cells
from control and infected mice is shown. Fluo-
rescence minus one (FMO) is shown in blue in
comparison to RORgT or FoxP3 shown in red.
(B and C) T cell proportions. Quantitation of the
frequency of (B) CD4+ RORgT+ cells (Th17) and
(C) CD4+ FoxP3+ cells (T-reg) is shown. Each
mouse was normalized to the respective controls
for each time point (average of controls for each
month). Horizontal bars indicate group mean
values. , uninfected control; +, H. pylori infected;
M, month. Statistical analysis was performed us-
ing the Mann-Whitney U test; *p < 0.05; **p < 0.01;
***p < 0.001.
See also Figure S4.(median 0.36%; Figure S6B) with levels similar in cohorts 1 and 2.
Comparative analysis using the LEfSe algorithm (Segata et al.,
2011) via the galaxy browser revealed numerous significant
abundance differences from phylum to species level (Table S1)
between control and infected mice. Taxa significantly and
consistently affected by the H. pylori infection (greater than or
equal to two time points in the same direction; Table S2) included
six species belonging to five orders and six families (Bacteroida-
ceae, Rikenellaceae, Lactobacillaceae, Lachnospiraceae, Erysi-
pelotrichaceae, and RF39; Table S3). To confirm our findings,
we also examined taxa in a third cohort of experimentally in-
fected mice (cohort 3), which were all confirmed to be H. pylori
positive by culture and PCR (data not shown). In this experiment,
the species and families identified as significantly different from
control micewere those that also had been identified in cohorts 11400 Cell Reports 14, 1395–1407, February 16, 2016 ª2016 The Authorsand 2 (Table S4). In summary, these
studies clearly show that H. pylori has
conserved effects on the mouse gastric
microbiome.
H. pylori Influences Intestinal
Microbial Community Structure
Next, we asked whether the presence of
H. pylori in the stomach also affected
downstream microbiota. Although alpha
diversity increased in fecal samples as
the mice aged, control and infected ani-
malsdid not significantly differ (FigureS5).
However, microbial community structure
(b-diversity) significantly differed by intes-
tinal locus, mouse cohort, and treatment
(Figure 6A). Before H. pylori challenge
(baseline), fecal samples from the subse-quent control and infected mice form a single cluster. Over the
course of the experiment, the fecal microbial populations in
both cohorts shifted monotonically across PC1, but control
and infected mice begin to significantly separate 3 months after
infection (p < 0.05; ADONIS test; Figure 6B; Table S5) and the
terminal cecal and ileal samples showed similar differences (Ta-
ble S5). Thus, in mice, H. pylori challenge not only influences the
population structure of the stomach but also more distally, with
differences increasing over time.
Relative Microbial Abundance in the Mouse Gut Is
Influenced by the Presence of H. pylori in the Stomach
H. pylori was not detected in the mouse feces by highly sensi-
tive PCR (data not shown), nor did high-throughput sequencing
detect Helicobacter-specific sequences in the fecal, ileal, and
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Figure 5. The Effect of H. pylori Colonization on Gastric Microbial Community Structure
Principal coordinates analysis (PCoA) of the unweighted UniFrac distances computed from 16S rRNA sequences from gastric samples at an even sampling (500)
depth.
(A) Comparison of cohort 1 (infected at 4 weeks) and cohort 2 (infected at 6 weeks), combined and separated by control or infected status, respectively. Right
panel shows average unweighted UniFrac distances (±SEM) comparing intragroup variation for the early or late cohort to the intergroup variation (early versus
late) for all mice, control mice, and infected mice. *** indicates that intragroup distance is significantly different from the intergroup distance; p < 0.005; t test.
(B) Cohort 1 and cohort 2, viewed separately, over time (months 1, 2, 3, and 6). Each gastric sample is represented as a colored circle; p values (ADONIS test) are
based on unweighted UniFrac distances Significance: p values < 0.05.
See also Figure S6 and Table S5.cecal samples, indicating that H. pylori effects on the intestinal
microbiota was indirect. Using the LEfSe algorithm, cohorts 1
and 2 were compositionally distinct (Figure S6B), but within
each cohort, controls and infected mice differed (Table S6).
We identified three species belonging to three families (Bacter-
oidaceae, Turicibacteraceae, and unclassified Clostridiales)
that were persistently altered in the H. pylori-colonized miceCell R(Tables S6 and S7); Turicibacter sp also was decreased in the
infected mice from cohort 3. Analyzing ileal and cecal samples
independently, we identified three persistently altered ileal
Firmicutes species (Lactobacillus other, Turicibacter, and Allo-
baculum species) and one cecal Firmicutes species (Turici-
bacter species) and one Tenericutes species (Anaeroplasma
species); in cohort 3 mice, features were similar (Table S4). Ineports 14, 1395–1407, February 16, 2016 ª2016 The Authors 1401
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Figure 6. The Effect of H. pylori Colonization on Gastro-intestinal Microbial Community Structures
PCoA of the unweighted UniFrac distances computed from 16S rRNA sequences at even sampling depth. (A) All samples were grouped for site, age at H. pylori
challenge (cohort), or treatment status and (B) fecal samples over time (baseline andmonths 3 and 6) of cohort 1 and cohort 2, respectively. Plots are organized as
in the legend to Figure 5. See also Figure S6 and Table S5.summary, gastric H. pylori infection and persistence affected
intestinal microbial composition with conserved stable differ-
ences emerging.
DISCUSSION
Although much of the world’s population is asymptomatically
colonized with H. pylori (Blaser and Atherton, 2004), risk for
peptic ulcer disease and for gastric adenocarcinoma and lym-
phoma is increased (Kusters et al., 2006). Disease outcomes1402 Cell Reports 14, 1395–1407, February 16, 2016 ª2016 The Authdepend on H. pylori strains, host genotype, and environmental
factors (e.g., salt intake; Castan˜o-Rodrı´guez et al., 2014).
H. pylori is both recognized by and directs host immune re-
sponses (Arnold et al., 2012; Lewis et al., 2011; Oertli et al.,
2012; Robinson et al., 2007), which could have further effects
on colonizing microbiota and host physiology. Both epidemio-
logic and experimental data provide evidence thatH. pylori colo-
nization early in life may protect against early-onset asthma
(Arnold et al., 2011a, 2011b; Chen and Blaser, 2007, 2008) and
infections (Perry et al., 2010; Rothenbacher et al., 2000), andors
there is substantial clinical and epidemiologic evidence for a
protective role in esophageal disease (Corley et al., 2008; Ru-
benstein et al., 2014; Thrift et al., 2012). Given the organism’s
complex relationship with human biology, both promoting and
preventing disease, animal models focusing on host and micro-
biota responses to H. pylori are useful.
The CagA+ H. pylori strain PMSS1 (Arnold et al., 2011b), the
pre-mouse parental strain of SS1 (Lee et al., 1997), colonizes
mice efficiently and induces differential immune responses and
disease outcomes, based on mouse age (Arnold et al., 2011a).
Low-level gastric H. pylori load in neonatal mice may reflect anti-
microbial functions of mother’s milk (Minoura et al., 2005) but in
any event appears to yield tolerogenic rather than immunogenic
responses (Arnold et al., 2012). We excluded possible effects of
nursing by challenging post-weaned (4-week-old)mice and sexu-
ally mature 6-week-old mice with H. pylori. For both cohorts, we
observed similar infection levels with long-term stability and with
anti-H. pylori IgM and IgG levels confirming continuing immuno-
logical recognition. As in other mouse experiments, we did not
detect responses to CagA in any of the infected mice, despite
the initial CagA+ functional status of PMSS1 (data not shown). It
is intriguing to speculate that the lack of immunological responses
to CagA may reflect cumulative effects, including low cagA-
expression in the non-acidic mouse stomach (Karita et al.,
1996) and/or functional loss in vivo (Arnold et al., 2011b; Barrozo
et al., 2013), in which cagY variation eliminates CagA delivery to
host cells (Barrozo et al., 2013).
Early in the experiment, infection levels varied substantially.
Because the same strain was used, differences may have been
stochastic or reflect host (and/or microbiota) characteristics;
subsequent convergence to a narrower range may reflect
conserved pressures and underscores the value of using inbred
mice and a single diet. Histological evaluation of the mice, also
confirming stable infection, showed corpus-dominant inflamma-
tion,mirroring typical human responseswithmixedmononuclear
and neutrophilic infiltrates around the gastric glands (Stolte and
Meining, 2001). The intensity of the interaction also is indicated
by the extent to which H. pylori influenced immune and inflam-
matory gastric gene expression (Table 1). Many of the genes up-
regulated only late play roles in apoptosis and oncogenesis, and
the increased expression of most Toll-like receptors (TLR) re-
flects a re-programming of innate immunity in response to
H. pylori persistence. Little is known about the interplay of
H. pylori with TLR3 (Pachathundikandi et al., 2015), but TLR3
and LPS-recognizing CD14 were both upregulated throughout
the study period. TLR3 recognizes dsRNA, but bacterial LPS
also induces its expression (Pan et al., 2011). Dendritic cells,
which play a crucial role inH. pylori recognition (Oertli andM€uller,
2012; Oertli et al., 2012; Shiu and Blanchard, 2013), may modu-
late the evolving responses to H. pylori components.
As expected, in the absence of a local inducing agent, genes
classically involved in pathogen recognition were not affected in
the lung. Smad3 and Smad5 were downregulated in the stom-
ach by H. pylori infection but were overexpressed at multiple
time points in the lung. Expression of the SMAD proteins, influ-
enced by cytokines of the transforming growth factor (TGF)-b
family, play crucial roles in T-helper cell differentiation. Smad3
negatively regulates Th17 cell development through FoxP3Cell R(Lu et al., 2010; Tone et al., 2008). In agreement with prior
studies (Futagami et al., 2006; Lee et al., 2012; Lundgren
et al., 2005), gastric T-reg and Th17 cell response-related genes
(e.g., STAT3, Ccr2, and Tgfb) were differentially expressed in
response to H. pylori (Data S1). However, we also observed
modestly higher levels of Th17 cells and a trend toward more
T-reg cells in pulmonary tissues of H. pylori-infected mice,
with effects enhanced in the cohort infected at a younger age.
These findings provide evidence that H. pylori gastric infection
might influence populations of specific immune cells in periph-
eral tissues, consistent with prior studies (Arnold et al., 2011a).
Throughout the experiment, we observed downregulation of
IL18, important for T-reg cell development in neonatal mice
(Oertli et al., 2012), which we speculate may affect later immune
responses. In adult mice, H. pylori infection usually yields Th1/
Th17-dominated responses (Shi et al., 2010) but also triggers
T-reg cell development, important for immune tolerance and
facilitating H. pylori persistence (Arnold et al., 2011b). Th17
and T-reg cells then also can migrate to and influence distant
tissues (Lim et al., 2008), with responses affected by indepen-
dent factors, including host age and genotype, and immune
system development. Although it remains formally possible
that during oral dosing the nasopharyngeal mucosa was
damaged exposing immune cells to H. pylori, we doubt that
such a scenario would occur in every mouse. We further spec-
ulate that only a chronic infection and not an acute injury can
result in prolonged T cell activation lasting several months.
The differences in Th17 responses between the infected and
control groups were not uniform throughout the experiment,
raising the question of whether this is related to the cohort
age differences or biases in flow cytometry analyses. Alterna-
tively, this phenomenon could be due to the complex immuno-
logical cross-regulation in the lung. Although only few genes in
the lung were affected consistently over time, early in the infec-
tion, there were significant changes in genes, including Tgfbr1,
IL4R, IL6R, and Smad3. Expression of these genes could
potentially influence Th17 cell numbers or suppress IL17 pro-
duction (see Data S1; Gagliani et al., 2015; Lu et al., 2010;
Tone et al., 2008).
The stomach is themajor site for production of ghrelin, centrally
involved inmetabolic homeostasis (De Vriese andDelporte, 2007;
Kojima et al., 1999). The differential ghrelin physiology in control
and H. pylori-infected mice that we observed, consistent with
prior studies (Bercik et al., 2009), provides further evidence of
the systemic effects of gastric H. pylori. The anti-inflammatory
properties of ghrelin, inhibiting Th17 cell differentiation (Xu et al.,
2015),might partially explainwhy,when levels are high (3months),
pulmonary Th17 populations are not significantly elevated. This
hormonal interaction may provide H. pyloriwith additional means
for evading host immune responses. Nevertheless, our findings
confirm that H. pylori infection is a dynamic process, involving
different cytokines, receptors, and signaling molecules over an
on-going temporal dimension.
Despite the relatively low H. pylori abundance in mice
compared to humans, physiology and immunity were substan-
tially affected. Because gastro-intestinal tract gene expression
is influenced by other micro-organisms, we asked whether
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composition locally in the stomach or distally in the intestine.
Although founder effects were important drivers of the variation
in bacterial community composition (Figure 6A), similar shifts in
the H. pylori-positive mice, across all three cohorts, indicate
conserved effects. The observed early population structure
shifts could reflect changes in niche physiology (e.g., altered
gastric pH and ghrelin production), whereas later shifts might
be driven by the cumulative and enhanced changes in the im-
mune and inflammatory responses to H. pylori having systemic
manifestations. Experimental approaches involving manipula-
tion of ghrelin, gastric pH, or gastric immune responses, in
isolation, could provide insight about which H. pylori-induced
perturbation has the greatest effect on the microbiota. We iden-
tified taxa that were influenced by the presence of H. pylori.
Although changes in the gastric microbiota were expected,
we also identified taxa affected in the intestines in all three co-
horts. These include members of the families Turicibactera-
ceae, Erysipelotrichaceae, and Desulfobirionaceae, species of
which have also been linked to host immune effects (Bisson-
Boutelliez et al., 2010; Devkota et al., 2012; Lukens et al.,
2014; Presley et al., 2010). The potential link between changes
in microbial composition due to the presence of H. pylori and
the possible effects on allergic diseases requires further inves-
tigation (Fujimura and Lynch, 2015).
In conclusion, this mouse model provides evidence that
gastricH. pylori infection affects local histologic, physiologic, im-
mune, andmicrobiologic features and indicates systemic effects
on the distal intestinal microbiota and in the lung. The gastric
niche is not isolated, and future studies are needed to extend
our understanding ofH. pylori colonization of humans to optimize
and individualize health strategies.EXPERIMENTAL PROCEDURES
Animal Experiments
All animal experiments were performed according to an IACUC-approved pro-
tocol, with mice housed in specific pathogen-free conditions and maintained
on a 12 hr light/dark cycle. Female C57BL/6 mice (Jackson Labs) were ob-
tained right after weaning at 3 or at 5 weeks of age, adapted to the animal fa-
cility, and then orally infected at either 4 (cohort 1) or 6 weeks (cohorts 2 and 3)
of age. Within each cohort, there was an infected and a control group. Mice
were gavaged twice (2 days apart) either with 0.5 ml sterile Brucella broth or
with H. pylori resuspended in Brucella broth (1 3 109 CFUs ml1). At months
1, 2, 3, and 6 (cohort 3 only at month 2) after infection, mice of each cohort
were fasted overnight and humanely euthanized with CO2 narcosis for spec-
imen collection. An overview of the description of the mouse model is shown
in Figure S1.
Strain Recovery and Histopathology
Following sacrifice, for each mouse (including controls), one longitudinal
quarter of the stomach was collected for strain recovery and one for histopa-
thology (see Supplemental Experimental Procedures).
Measurement of H. pylori-Specific Antibodies and CagA Antibodies
in Mice by ELISA
Blood was obtained from living animals by sub-mandibular bleeding or at sac-
rifice, blood cells and serumwere separated by centrifugation (300 g for 10min
at room temperature), and the serum was frozen. Anti-H. pylori immunoglob-
ulin G (IgG) and M (IgM) levels in the mouse plasma were determined, using
a modification of a method with high sensitivity and specificity for human
H. pylori positivity, as described (Dubois et al., 1994). The protocol was adapt-1404 Cell Reports 14, 1395–1407, February 16, 2016 ª2016 The Authed to mice by using mouse-specific IgG and IgM secondary antibodies (see
Supplemental Experimental Procedures).
Isolation of Leukocytes from Lungs and Spleens
Spleens and lungs were dissected at sacrifice; for the lungs, the right lobe was
mincedwith a razor blade and incubated in RPMI supplementedwith 10%FCS
and 0.5 mg/ml collagenase IA and incubated for 30 min at 37C. Lungs and
spleens were homogenized between frosted slides in RPMI and then passed
through a 40-mm nylon mesh filter (BD Biosciences). Cells were pelleted at
300 g for 5 min and red blood cells lysed by addition of ACK (ammonium-chlo-
ride-potassium) lysis buffer (Life Technologies) for 7 min at room temperature,
washed with RPMI, and re-suspended in Dulbecco PBS for staining.
Lymphocyte Staining and Analysis of Lymphocyte Subsets by Flow
Cytometry
Cells were incubated with LIVE/DEAD Fixable Blue dead cell stain (Life Tech-
nologies) for 10 min at 4C to identify live cells. Splenic and pulmonary leuko-
cytes were identified using the following antibodies: CD3-APC-Cy7 (BD
Biosciences); CD4-PE-Alexa Fluor 610 (Invitrogen); CD8-V500 (BD Biosci-
ences); RORgt-PE (eBioscience); Foxp3-PE-Cy7 (eBioscience); and IL17a-
Alexa Flour 700 (BioLegend). For staining of nuclear markers, cells were first
incubated with surface antibodies (each at 1:50 in FACS buffer) along with FC
block (anti-mouse CD16/CD32; eBioscience) at 1:200 for 30 min at 4C, fixed
and permeabilized with fixation/permeabilization buffer (eBioscience), and
subsequently incubated with the nuclear antibodies in permeabilization buffer
(eBioscience) for 30 min at 4C. Prior to IL17 staining, isolated lymphocytes
were cultured for 4 hr at 37C in presence of PMA, ionomycin (Sigma), and
GolgiPlug (BD Biosciences). All cells were acquired on a LSRII (Becton Dick-
inson) and analyzed using FlowJo software (Tree Star), with graphics and sta-
tistical tests performed using the GraphPad Prism software. To determine
statistical significance between groups, we used the Mann-Whitney test.
The applied gating strategy is shown in Figure S4. The proportion of
CD4+RoRgt+, CD4+FoxP3+, and CD4+IL17a+ cells were expressed as per-
centages of total CD4+ cells. For each time point, the value observed in each
mouse then was normalized using the mean value from control mice of each
cohort and month, respectively, as denominator.
Nanostring and Hormone Measurements
At months 1, 3, and 6, immune gene expression of cohort 1 mice was
measured by the nCounter GX Mouse Immunology Panel (NanoString). Hor-
mones were measured in both cohorts at all time points using the Millipore
Mouse Gut Hormone Panel (Millipore) using a Luminex 200 (Millipore) analyzer
(see Supplemental Experimental Procedures).
DNA Library Preparation, Sequencing, and Sequence Analysis
DNA extraction was done using the Power Soil DNA isolation kit (Mo Bio Lab-
oratories), the V4 region of the 16S rRNA gene was amplified, and barcoded
fusion primers were attached through PCR, as described (Caporaso et al.,
2012). Of the 563 samples, the average depth of coverage was 3,504 ±
3.449 sequences per sample. Six samples that had coverage below 500 reads
were eliminated from the downstream analysis. Taxonomywas assigned using
the open reference method in QIIME (Caporaso et al., 2010), with an RDP con-
fidence interval of 50%, and the sequences clustered at 97% identity from the
GreenGenes 2013May database release were used as a reference (McDonald
et al., 2012; see Supplemental Experimental Procedures).
Statistical Analysis
Statistical analysis of colonization, antibody and ghrelin response, and histol-
ogy scoring data was done with GraphPad Prism 5 using Mann-Whitney
U tests or for multiple group comparisons and Kruskal-Wallace tests followed
by Mann-Whitney U test.
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